Histamine augments β2-adrenoceptor-induced cyclic AMP accumulation in human prostate cancer cells DU-145 independently of known histamine receptors

Biochemical Pharmacology

Volumn 73, Issue 6, 2007, Pages 814-823

  Ramos Jiménez, Judith ^a,b   Soria Jasso, Luis Enrique ^c   López Colombo, Aurelio ^d   Reyes Esparza, Jorge Alberto ^e   Camacho, Javier ^b   Arias Montaño, José Antonio ^a  

^a Cinvestav   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

Author keywords

Adrenaline; Adrenoceptors; cAMP; DU 145 cells; Histamine; Noradrenaline

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADRENALIN; ALPHA METHYLHISTAMINE; ANDROGEN; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; CLOBENPROPIT; CYCLIC AMP; DIHYDROALPRENOLOL; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTAMINE RECEPTOR; IMIDAZOLE; IMIDAZOLE DERIVATIVE; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; NORADRENALIN; TRITIUM; ZINC;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; ISOTOPE LABELING; MEMBRANE BINDING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SECOND MESSENGER; MALE; METABOLISM; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CYCLIC AMP; DIHYDROALPRENOLOL; HISTAMINE; HUMANS; ISOPROTERENOL; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, HISTAMINE; ZINC;

EID: 33846860642     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.11.022     Document Type: Article

References (48)

1. Feldman B.J., and Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 1 (2001) 34-45
2. s signaling in prostate cancer cells. J Biol Chem 280 (2005) 11583-11589
3. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.-C., Shankley N.P., Young J.M., et al. Classification of histamine receptors. Pharmacol Rev 49 (1997) 253-278
4. Haas H., and Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nature Rev Neurosci 4 (2003) 121-130
5. Leurs R., Smit M.J., and Timmerman H. Molecular and pharmacological aspects of histamine receptors. Pharmacol Ther 66 (1995) 413-463
6. 3 receptor drugs. Nat Rev Drug Discov 4 (2005) 107-120
7. 4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci 26 (2005) 462-469
8. Panula P., Lintunen M., and Karlstedt K. Histamine in brain development and tumors. Semin Cancer Biol 10 (2000) 11-14
9. 1 receptor activation inhibits the proliferation of human prostatic adenocarcinoma cells DU-145. Prostate 48 (2001) 179-187
10. Alexander S.P.H., Mathie A., and Peters J.A. Guide to receptors and channels. Br J Pharmacol 147 (2006) S13-S14
11. 2- and β-Adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147 (2006) S88-S119
12. Nagmani R., Pasco D.S., Salas R.D., and Feller D.R. Evaluation of β-adrenergic receptor subtypes in the human prostate cancer cell line-LNCaP. Biochem Pharmacol 65 (2003) 1489-1494
13. Selbie L.A., and Hill S.J. G protein-coupled receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol Sci 19 (1998) 87-93
14. Sunahara R.K., Dessauer C.W., and Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36 (1996) 461-480
15. Cooper D.M.F. Regulation and organization of adenylyl cyclases and cAMP. Biochem J 375 (2003) 517-529
16. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem 72 (1976) 248-254
17. Alexander S.P.H. The measurement of cyclic AMP levels in biological preparations. In: Kendall D.A., and Hill S.J. (Eds). Signal transduction protocols (1995), Humana Press, Totowa 79-89
18. 50) of an enzymatic reaction. Biochem Pharmacol 22 (1973) 3099-3108
19. 2-imidazoline sites in rat prostate. Effect of castration and aging. Biochem Pharmacol 51 (1996) 455-459
20. Eglen R.M., Hudson A.L., Kendall D.A., Nutt D.J., Morgan N.G., Wilson V.G., et al. 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol Sci 19 (1998) 381-390
21. Stone K.R., Mickey D.D., Wunderli H., Mickey G.H., and Pauloson D.F. Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 21 (1978) 274-281
22. Greenlee R.T., Taylor M., Bolden S., and Wingo P.A. Cancer statistics: 2000. CA Cancer J Clin 50 (2000) 7-33
23. 2 adrenoceptor. EMBO J 16 (1997) 6737-6747
24. Goepel M., Wittmann A., Rübben H., and Michel M.C. Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urol Res 25 (1997) 199-206
25. Tsuji T., Azuma H., Yamaguchi T., and Oshima H. A possible role of decreased relaxation mediated by β-adrenoceptors in bladder outlet obstruction by benign prostatic hyperplasia. Br J Pharmacol 107 (1992) 803-807
26. 2-adrenergic receptors in a mouse cell line previously lacking β-receptors. J Biol Chem 262 (1987) 14843-14846
27. Tate K.M., Briend-Sutren M.M., Emorine L.J., DElavier-Klutchko C., Marullo S., and Strosberg A.D. Expression of three human beta-adrenergic-receptor subtypes in transfected Chinese hamster ovary cells. Eur J Biochem 196 (1991) 357-361
28. 2-Adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol 35 (1989) 295-303
29. 3-adrenergic receptor. Science 245 (1989) 1118-1121
30. 1 receptors potentiate cyclic AMP accumulation in guinea pig cerebral cortical slices. Mol Pharmacol 33 (1988) 626-633
31. 1-histaminergic receptors. J Neurosci 5 (1985) 362-368
32. 2-receptors in the cAMP response in guinea pig brain slices: effect of phorbol esters and calcium. Mol Pharmacol 33 (1988) 38-43
33. 1 receptor. II. Stable expression in Chinese hamster ovary cells reveals the interaction with three major signal transduction pathways. J Neurochem 62 (1994) 519-527
34. 1-mediated phospholipase C and adenylyl cyclase signaling. J Pharmacol Exp Ther 311 (2004) 274-281
35. Maruko T., Nakhara T., Sakamoto K., Saito M., Sugimoto N., Takuwa Y., et al. Involvement of the βγ subunits of G proteins in the cAMP response induced by stimulation of the histamine H1 receptor. Naunyn-Schmiedeberg's Arch Pharmacol 372 (2005) 153-159
36. Engel K., and Wang J. Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68 (2005) 1397-1407
37. Ogasawara M., Yamauchi K., Satoh Y., Yamaji R., Inui K., Jonker J.W., et al. Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism. J Pharmacol Sci 101 (2006) 24-30
38. Slitt A.L., Cherrington N.J., Hartley D.P., Leazer T.M., and Klaassen. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 30 (2002) 212-219
39. Schneider E., Machavoine F., Pléau J.-M., Bertron A.-F., Thurmond R.L., Ohtsu H., et al. Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels. J Exp Med 202 (2005) 387-393
40. 2 imidazoline and s binding sites in the rat and human stomach. J Pharmacol Exp Ther 285 (1998) 170-177
41. 2 adrenergic receptor. Proc Natl Acad Sci USA 98 (2001) 5997-6002
42. 2 adrenoceptor. J Biol Chem 279 (2003) 686-691
43. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, et al. Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther., in press [www.jpet.aspetjournals.org/cgi/reprint/jpet.106.104463v1].
44. 2 adrenergic receptor. J Peptide Res 60 (2002) 317-321
45. 2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J Biol Chem 280 (2005) 22165-22171
46. Christopoulos A., and Kenakin T. G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54 (2002) 323-374
47. 2+. Mol Pharmacol 61 (2002) 65-72
48. 2 adrenergic receptor. J Biol Chem 278 (2003) 352-356